Steven T. Okino et al. similarly concluded that the silencing of GSTP1 increases tumor susceptibility and promotes tumor progression and found that DNA methylation and histone modification silenced GSTP1 expression in prostate cancer; the order of alteration of these two epigenetic marks remains controversial [17]. This evidence concerns the gene GSTP1 and prostate carcinoma.